| Primary |
| Hypertension |
21.8% |
| Diabetes Mellitus |
12.9% |
| Chronic Obstructive Pulmonary Disease |
11.9% |
| Osteomyelitis |
7.9% |
| Pain |
7.9% |
| Urinary Tract Infection |
7.9% |
| Infection |
5.0% |
| Diabetic Foot |
4.0% |
| Drug Use For Unknown Indication |
4.0% |
| Thrombosis Prophylaxis |
4.0% |
| Cellulitis |
2.0% |
| Escherichia Urinary Tract Infection |
2.0% |
| Surgery |
2.0% |
| Abdominal Infection |
1.0% |
| Appendicitis |
1.0% |
| Convulsion |
1.0% |
| Groin Infection |
1.0% |
| Insomnia |
1.0% |
| Paronychia |
1.0% |
| Pneumonia |
1.0% |
|
| Rash |
14.7% |
| Convulsion |
11.8% |
| Mental Status Changes |
8.8% |
| Status Epilepticus |
8.8% |
| Dyspnoea |
5.9% |
| Grand Mal Convulsion |
5.9% |
| Renal Failure Acute |
5.9% |
| Angioedema |
2.9% |
| Arthritis |
2.9% |
| Bundle Branch Block Left |
2.9% |
| Diarrhoea |
2.9% |
| Drug Hypersensitivity |
2.9% |
| Drug Level Decreased |
2.9% |
| Hallucination |
2.9% |
| Hyperkalaemia |
2.9% |
| Hypotension |
2.9% |
| Incorrect Drug Administration Duration |
2.9% |
| Loss Of Consciousness |
2.9% |
| Miosis |
2.9% |
| Muscle Twitching |
2.9% |
|
| Secondary |
| Product Used For Unknown Indication |
37.7% |
| Urinary Tract Infection |
8.5% |
| Pneumonia |
8.2% |
| Bacteraemia |
5.2% |
| Urosepsis |
5.2% |
| Renal Transplant |
4.0% |
| Oral Candidiasis |
3.6% |
| Renal Failure Acute |
3.6% |
| Chronic Obstructive Pulmonary Disease |
3.0% |
| Cough |
2.7% |
| Hereditary Angioedema |
2.7% |
| Rhodococcus Infection |
2.7% |
| Bacterial Infection |
2.4% |
| Diverticulitis |
1.8% |
| Gram Stain Negative |
1.8% |
| Intestinal Perforation |
1.8% |
| Abdominal Infection |
1.2% |
| Empyema |
1.2% |
| Escherichia Infection |
1.2% |
| Prophylaxis |
1.2% |
|
| Urosepsis |
17.5% |
| Immunosuppressant Drug Level Increased |
14.0% |
| Diarrhoea |
10.5% |
| White Blood Cell Count Increased |
10.5% |
| Clostridium Difficile Infection |
5.3% |
| Drug Level Increased |
5.3% |
| Convulsion |
3.5% |
| Drug Interaction |
3.5% |
| Enterocolitis |
3.5% |
| Renal Failure Acute |
3.5% |
| Renal Impairment |
3.5% |
| Splenic Infarction |
3.5% |
| Urinary Tract Infection |
3.5% |
| Angioedema |
1.8% |
| Clostridial Infection |
1.8% |
| Death |
1.8% |
| Delirium |
1.8% |
| Drug Ineffective |
1.8% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
1.8% |
| Gastric Ulcer |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
37.8% |
| Drug Use For Unknown Indication |
30.6% |
| Multiple Myeloma |
3.6% |
| Hiv Infection |
2.9% |
| Prophylaxis |
2.7% |
| Klebsiella Infection |
2.6% |
| Immunosuppression |
2.4% |
| Hypertension |
2.0% |
| Ill-defined Disorder |
1.9% |
| Pneumonia |
1.8% |
| Abdominal Infection |
1.4% |
| Staphylococcal Infection |
1.4% |
| Infection |
1.3% |
| Bacterial Infection |
1.2% |
| Medical Diet |
1.1% |
| Pneumocystis Jiroveci Pneumonia |
1.1% |
| Pyrexia |
1.1% |
| Surgery |
1.1% |
| Crohn's Disease |
1.0% |
| Depression |
1.0% |
|
| Weight Decreased |
14.8% |
| Pathogen Resistance |
7.4% |
| Blood Amylase Increased |
6.2% |
| Thrombosis |
6.2% |
| Tricuspid Valve Incompetence |
6.2% |
| Urinary Tract Infection |
6.2% |
| Nausea |
4.9% |
| Pyrexia |
4.9% |
| Sepsis |
4.9% |
| Small Intestinal Obstruction |
4.9% |
| Thrombocythaemia |
4.9% |
| White Blood Cell Count Decreased |
4.9% |
| Arrhythmia |
3.7% |
| Streptococcal Infection |
3.7% |
| Ventricular Tachycardia |
3.7% |
| Abscess |
2.5% |
| Anaemia |
2.5% |
| Clostridium Difficile Infection |
2.5% |
| Colitis Ulcerative |
2.5% |
| Confusional State |
2.5% |
|
| Interacting |
| Drug Use For Unknown Indication |
31.6% |
| Convulsion |
7.9% |
| Immunosuppression |
7.9% |
| Cardiac Failure |
5.3% |
| Cardiac Insufficiency |
5.3% |
| Epilepsy |
5.3% |
| Insomnia |
5.3% |
| Respiratory Tract Infection |
5.3% |
| Cardiovascular Event Prophylaxis |
2.6% |
| Drug Hypersensitivity |
2.6% |
| Gastrointestinal Disorder |
2.6% |
| Hypertension |
2.6% |
| Pneumonia Bacterial |
2.6% |
| Pneumonia Klebsiella |
2.6% |
| Product Used For Unknown Indication |
2.6% |
| Prophylaxis |
2.6% |
| Pyrexia |
2.6% |
| Thrombosis Prophylaxis |
2.6% |
|
| Renal Failure Acute |
25.0% |
| Drug Interaction |
12.5% |
| Drug Level Decreased |
12.5% |
| Myocardial Infarction |
12.5% |
| Rash |
12.5% |
| Transplant Rejection |
12.5% |
| Tremor |
12.5% |
|
